Abstract accepted for poster presentation at the International Investigative Dermatology Conference in Orlando, May 16-19 2018
Follicum AB (“Follicum” or “the Company”) a clinical stage company focused on developing a novel peptide to promote hair growth, today, May 7, announces that an abstract has been accepted for poster presentation during the International Investigative Dermatology Conference to be held in Orlando, USA May 16-19 2018. The abstract will be presented by Follicum´s partner, ImaBiotech - a CRO with innovative imaging services. The details of the abstract can be found below.Poster session: Poster Display session.Abstract title: Analysis of Mice Skin Distribution Using MALDI-MSI after Subcutaneous